Injection Pen Market Is Expected to Reach USD 80.51 Billion by 2031: Allied Market Research

According to the report published by Allied Market Research, the global injection pen market was estimated at $37.89 billion in 2021 and is expected to hit $80.51 billion by 2031, registering a CAGR of 7.8% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios. The report is a helpful source of information for leading market players, new entrants, investors, and stakeholders in devising strategies for the future and taking steps to strengthen their position in the market.

Request Sample PDF Brochure- https://www.alliedmarketresearch.com/request-sample/7994

The research provides detailed segmentation of the global injection pen market based on therapy, end users, type, and region. The report discusses segments and their sub-segments in detail with the help of tables and figures. Market players and investors can strategize according to the highest revenue-generating and fastest-growing segments mentioned in the report.

Based on therapy, the diabetes segment held the highest share in 2021, accounting for more than three-fifths of the global injection pen market revenue and is expected to continue its leadership status during the forecast period. The same segment is expected to register the highest CAGR of 8.5% from 2022 to 2031. The report also discusses growth hormones, osteoporosis, fertility, and others segments.

Based on end users, the home-care settings segment accounted for the highest share in 2021, holding more than two-thirds of the global injection pen market revenue, and is expected to maintain its lead in terms of revenue during the forecast period. The same segment, however, is estimated to grow at the highest CAGR of 8.2% from 2022 to 2031. The hospital and clinics segment is also analyzed in the report.

Based on type, the disposable injection pen segment held the major share in 2021, garnering nearly three-fourths of the global injection pen market revenue and is projected to maintain its dominance by 2031. The same segment would also display the fastest CAGR of 8.0% from 2022 to 2031. The independent dealer segment is also studied in the report.

For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/7994

Based on region, North America held the largest share in 2021, contributing to more than two-fifths of the global injection pen market revenue, and is projected to maintain its dominant share in terms of revenue during the forecast period. In addition, the Asia-Pacific region is expected to manifest the fastest CAGR of 9.3% from 2022 to 2031. The other regions analyzed in the study include Europe and LAMEA.

The leading market players analyzed in the global injection pen market report include Novartis AG, Merck Group, Sanofi, Biocon, Pfizer Inc., Novo Nordisk A/S, Ypsomed AG, Dickinson and Company, AstraZeneca, Eli Lilly and Company, and Becton. These players have adopted different strategies such as new product launches, collaborations, expansion, joint ventures, agreements, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, product portfolio, operating segments, and strategic moves of market players to showcase the competitive scenario.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.